AzTrials
AzTrials

PacemakerNCT00822965

Enhancing Knowledge Implantable Cardioverter-Defibrillators (ICDs)

An observational study of Pacemaker and Implantable Cardioverter-Defibrillators, run by M.D. Anderson Cancer Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The specific aims of the patient intervention are to: 1. increase patient knowledge about pacemakers (PM) and implantable cardioverter-defibrillators (ICDs) 2. help patients to identify if their PM or ICD has been interrogated 3. improve patient's physician-patient communication skills 4. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Questionnaires, Phone Interviews and Educational Packet
How many people
104 participants
Where
1 siteUnited States
Study dates
Jan 2009to Jan 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Consecutive patients presented to UTMDACC Preoperative Consultation Clinic from January 1, 2000 to November 15, 2008 with an implanted pulse generator.

Who may be able to join

  • Consecutive patients (beginning with most recent date) who presented to UTMDACC Preoperative Consultation Clinic from January 1, 2000 to November 15, 2008 with an implanted pulse generator.
  • English-speaking (Resources to translate materials and provide interviews in Spanish language or languages other than English are not available for this study).
  • Adult patients 18 years of age or older.

Who cannot join

  • Patients who fail to consent to participate.
  • Patients with self-report of hearing impairment, sight, or reading impairment that would hinder ability to complete written surveys
  • Patients who have a second implant

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Texas MD Anderson Cancer Center

    Houston, Texas, 77030

Other trials in United States

About this study

Official title: Patient Knowledge of Pacemaker/Implantable Cardioverter-Defibrillator-Phase II

The specific aims of the patient intervention are to:

  1. increase patient knowledge about pacemakers (PM) and implantable cardioverter-defibrillators (ICDs)
  2. help patients to identify if their PM or ICD has been interrogated
  3. improve patient's physician-patient communication skills
  4. teach patients how to identify if their device has been recalled
  5. train patients what to do in case of a device recall

The educational interventions proposed, if proven to be effective by this pilot, will provide a low-cost, reproducible intervention to improve the clinical care and safe management of pacemakers (PM) and implantable cardioverter-defibrillators (ICD) in patients. The goal of the intervention will be to promote the safe use of implantable pulse generators.

Read the detailed description

If you agree to take part in this study, you will complete 3 sets of questionnaires (at the beginning of the study, at 2-months and at 4-months) which will be sent to you and returned by you through the mail. This will not require you to travel to M.D. Anderson. In addition to the questionnaires, you will also complete 2 follow-up phone interviews.

Questionnaires:

The first set of questionnaires will be mailed to your home. The questionnaires will ask questions about your anxiety level and how much you know about pacemakers or implantable cardioverter-defibrillators. There will also be questions about your gender, age, ethnicity, and race. The questionnaires will take about 25 minutes to complete. When you are finished, you will mail the questionnaires to the study staff. An envelope with pre-paid postage will be provided.

Educational Packet:

After you have completed the questionnaires, you will receive an educational packet in the mail. The packet will have a DVD or a video (depending on whether you tell us you have a DVD player or a VHS player) with information on medical devices, device recall information (when and why certain devices have been recalled in the past), a list of on-line resources and benefits of routine follow-up.

Phone Interview:

The study staff will call your home 1 week after you receive the educational packet for a follow-up interview. A member of the study staff will review the packet with you. The phone call will last about 20 minutes.

Additional Questionnaires:

Approximately 2 months and at 4 months after you complete the first set of questionnaires, an additional set of questionnaires will be mailed to you. You will be asked to complete the same questionnaires as you did in the first set. At 4 months an additional questionnaire about the information in the educational packet and how useful it was to you will be included. The questionnaires will take about 25 minutes to complete. When you are finished, you will mail the questionnaires to the study staff. An envelope with pre-paid postage will be provided.

Length of Study:

You participation on this study is complete once you have completed the additional questionnaires.

This is an investigational study. Up to 104 patients will be enrolled in this study. All will be enrolled at M. D. Anderson.

Being tested
Questionnaires, Phone Interviews, Educational Packet
Keywords
Pacemakers, PM, Implantable cardioverter-defibrillators, ICD, Implantable pulse generators, Educational Interventions

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnairesOther

    Also called Survey

    3 sets of questionnaires at the beginning of the study, at 2-months and at 4-months.

  • Phone InterviewsOther

    2 follow-up phone interviews.

  • Educational PacketBehavioural

    Video or DVD of device information, updates, recalls, on-line resources and benefits of routine follow-up for device(s).

Study groups in NCT00822965
Study groupRoleWhat they receive
Patient Knowledge AssessmentsQuestionnaires + Phone Interview
Receives: Other: Questionnaires; Other: Phone Interviews; Behavioral: Educational Packet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient knowledge about pacemakers (PM) and implantable cardioverter-defibrillators (ICDs)

    Measured: Total knowledge score evaluated at baseline and at 2-month and 4-month post educational intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jan 2009 (estimated)
  2. Study startJan 2009
  3. Primary completionJan 2015
  4. Study completionJan 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
104 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00822965
Sponsor's protocol ID
2008-0163
Status last verified
Jan 2016
First submitted
13 Jan 2009
Last updated
7 Jan 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Pacemaker and Implantable Cardioverter-Defibrillators, run by M.D. Anderson Cancer Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jan 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient knowledge about pacemakers (PM) and implantable cardioverter-defibrillators (ICDs) (time frame: Total knowledge score evaluated at baseline and at 2-month and 4-month post educational intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in